Sergey Babak

Sergey Babak

Auto-generated profile, based on publicly available information

Sergey Babak

Russian University of Medicine

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2023 in PULMONOLOGIYA
Verified
Journal Article
Open access
PDF file
MKM. Yu. Kameneva
M. Yu. Kameneva
АCАlexander Cherniak
Аlexander Cherniak
ZAZaurbek Aisanov
Zaurbek Aisanov
SASergey Avdeev
Sergey Avdeev
SBS. L. Babak
S. L. Babak
MCM. I. Chushkin
M. I. Chushkin
Spirometry is the most common method to assess respiratory function. It is widely used to obtain objective information for the diagnosis of respiratory diseases and monitoring the functional state of the respiratory system. In 2014, the Russian Respiratory Society approved the technical standards for performing spirometry. Improvements in measuring devices have necessitated updating technical standards and standardizing the result interpretation algorithm.Methods. This document on spirometry was prepared by a joint group of experts from the Russian Respiratory Society and the Russian Association of Specialists in Functional Diagnostics, who have experience in performing spirometry in accordance with quality criteria, analyzing the results of the study, and developing national standards.Results. The 2014 Spirometry Technical Standards were revised, including the addition of quality criteria for measurements and test quality assessment. Where necessary, evidence was provided to support the change. The experience and knowledge of the expert group members were used to develop these recommendations.Conclusion. Standards for spirometry and bronchodilator test and the result interpretation algorithm are presented to improve the measurement quality and consistency of data interpretation.

30 March 2019 in The Russian Archives of Internal Medicine
Verified
Journal Article
Open access
PDF file
MGM. V. Gorbunova
M. V. Gorbunova
SBS. L. Babak
S. L. Babak
AMA. G. Malyavin
A. G. Malyavin
Рациональная антигипертензивная терапия пациентов с обструктивным апноэ сна

29 November 2021 in The Russian Archives of Internal Medicine
Verified
Journal Article
Open access
PDF file
SBS. L. Babak
S. L. Babak
MGM. V. Gorbunova
M. V. Gorbunova
AMA. G. Malyavin
A. G. Malyavin
ISI. V. Shashenkov
I. V. Shashenkov
The concept of tobacco harm reduction (THR) is a speculative and controversial topic in the context of the international battle against the use of all types of tobacco. This concept involves providing tobacco users who are unable or unwilling to quit smoking or using other types of tobacco (snuff, chewing), with modified risk tobacco product (MRTP) for continued use. Skepticism about THR is huge and is associated with the negative experience of tobacco companies to produce cigarettes with a low content of tobacco tar/nicotine, which should have had significantly lower health risks than conventional cigarettes. Paradoxically, such an experience served as a springboard to an increase in the number of tobacco products that potentially have the properties of MRTP. Moreover, some members of the anti-smoking coalition, including WHO, consider the transition of tobacco smokers to MRTP as a strategy with great potential. However, the European Group of Experts believes that the MRTP strategy does not work and will lead to another generation of young people getting used to tobacco. In this article, we have critically analyzed the history of the past and present of tobacco products, myths and contradictions around them. We have tried to evaluate the modern concept of S THR as objectively as possible, which has a high potential for a real reduction in the number of deaths associated with smoking.

30 March 2021 in The Russian Archives of Internal Medicine
Verified
Journal Article
Open access
PDF file
MKMaria Alexandrovna Karnaushkina
Maria Alexandrovna Karnaushkina
ASA. D. Strutynskaya
A. D. Strutynskaya
SBS. L. Babak
S. L. Babak
MGM. V. Gorbunova
M. V. Gorbunova
The «bronchiolitis» unites a heterogeneous group of diseases of inflammatory nature, the anatomical substrate of which are Airways without cartilage wall-bronchioles. Despite the etiological diversity of bronchiolitis, pathomorphological they manifest a certain set of changes in the lung tissue. This determines the similarity of visualization of different types of bronchiolitis during computed tomography of the chest. The key to successful diagnosis of bronchiolitis is a clear understanding of the definition of this pathology and a comprehensive analysis by a Clinician of anamnestic, clinical, laboratory and radiological data. In this article, we will consider three types of cellular bronchiolitis, which are combined by imaging on computed tomography of the chest pattern «tree in the kidneys»: infectious, aspiration bronchiolitis and diffuse panbronchiolitis.


27 January 2021 in The Russian Archives of Internal Medicine
Verified
Journal Article
Open access
PDF file
AMA. G. Malyavin
A. G. Malyavin
SBS. L. Babak
S. L. Babak
MGM. V. Gorbunova
M. V. Gorbunova
In the presented clinical review, we evaluated the possibilities of drug and non-drug strategies for eliminating and preventing pathophysiological changes in the respiratory system of post-COVID-19 patients. We offer up-to-date rehabilitation algorithms based on the assessment of the severity of clinical manifestations of COVID-19, the possibilities of rehabilitation techniques and the patient’s personal compliance with their implementation.